黑料吃瓜群网

DVT meds help reduce risk


Friday, 02 August, 2019

DVT meds help reduce risk

New kinds of blood thinners are signalling changes to the treatment of deep vein thrombosis (DVT) and a potential reduction in risk of blood clots, a review has found.

Alfred Health General Medicine Deputy Director Associate Professor Harry Gibbs and co-authors examined the latest recommendations for the treatment of DVT in an article for the journal .

The authors said that a new kind of blood thinner was changing the way DVT was treated and that more people should consider long-term use of these newer blood thinners to reduce the risk of DVT.

鈥淒eep vein thrombosis occurs when a blood clot forms in a deep vein in your body, usually in the leg,鈥 Associate Professor Gibbs said.

鈥淚t can be dangerous if it breaks loose and lodges itself in your lungs.

鈥淧eople who have had DVT have a higher risk of having another one.

鈥淯sing blood thinners reduces the risk of recurrence by 80% but comes with a risk of bleeding.鈥

New blood thinners such as rivaroxaban and apixaban had a lower risk of bleeding compared to warfarin, the old standard in blood thinner treatment for DVT, the authors said.

Also, unlike with warfarin, there was no need to inject blood thinners at the start of treatment. There was also no need for frequent blood tests.

鈥淚n the past, only the people at highest risk of DVT used warfarin in the long term, despite the risk of bleeding, to reduce their risk of DVT,鈥 Associate Professor Gibbs said.

鈥淏ecause the new blood thinners are easy to use and have a low risk of bleeding, even people at moderate risk of DVT should consider using the new blood thinners long term to reduce their risk.鈥

As with all treatments, for every patient the benefits of using blood thinners needed to be weighed up against potential harm, the authors said.

Image credit: 漏stock.adobe.com/au/designer491

Related News

Victoria's Q3 median ED wait times the lowest on record

Victoria's quarter three performance data (January–March) has shown improvement across...

Irregularities in a clinician's cases prompt 15-month lookback

St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...

Two researchers receive $899,000 in cardiovascular funding

In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd